Study of Contrast - Induced Nephropathy After Intravenous Contrast Procedures at Sohag University Hospitals

Launched by SOHAG UNIVERSITY · May 2, 2025

Keywords

ClinConnect Summary

This clinical trial is studying a condition called contrast-induced nephropathy (CIN), which can occur after patients receive a special dye called iodinated contrast during certain medical procedures, like angiograms. CIN can lead to kidney problems, particularly in patients who already have risk factors such as diabetes or existing kidney issues. The study aims to understand how often CIN happens among patients at Sohag University Hospitals who have received intravenous contrast, by monitoring changes in their blood test results related to kidney function.

To participate in this trial, individuals must be at least 18 years old and have undergone a single intravenous contrast procedure. However, those with severe kidney disease, certain heart conditions, or a history of allergic reactions to contrast dye are not eligible. Participants will have their kidney function monitored over the days following the procedure to see if there are any changes. This research is important because understanding how common CIN is can help doctors take better care of their patients and prevent kidney damage in those at risk.

Gender

MALE

Eligibility criteria

• Inclusion Criteria:
• • 1- Inpatients and outpatients aged 18years and above who underwent single intravenous Contrast procedures.
• Exclusion criteria:
• • 1. Patients below 18 years, failure to obtain consent.
• • 2. Patients with ESRD/ on maintenance hemodialysis.
• • 3. New-York Heart Association class IV Congestive Cardiac Failure (CCF) or patients with cardiogenic shock .
• • 4. History of hypersensitivity to contrast in the past or exposure to contrast in the last 24-48 hours, 5-nursing/pregnant subjects.
• • 5. Patients with malignancy or other organ failure like decompensated liver cirrhosis